![Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial | Future Oncology Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2017-0457/asset/images/medium/figure1.gif)
Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial | Future Oncology
![PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926. PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.](https://www.researchgate.net/profile/Antonio-Ponzetto/publication/267324205/figure/tbl3/AS:667836607369220@1536236063090/Nanoparticles-for-cancer-treatment-in-preclinical-trials_Q320.jpg)
PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.
![Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark-Little-2/publication/338203271/figure/fig1/AS:963226976129024@1606662615457/Absolute-excess-risk-of-basal-cell-carcinoma-95-CI-over-baseline-level-defined-by_Q640.jpg)
Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram
![Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f5da04fac11c2ecde69ee95d887325b41609a7f0/3-Figure2-1.png)
Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar
![PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926. PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.](https://www.researchgate.net/profile/Antonio-Ponzetto/publication/267324205/figure/tbl2/AS:392171237724163@1470512317518/Nanoparticles-for-Cancer-Treatment-Approved-and-or-in-Clinical-Trials_Q320.jpg)
PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.
![Perfluorodecalin‐infused patch in picosecond and Q‐switched laser‐assisted tattoo removal: Safety in Fitzpatrick IV–VI skin types - Vangipuram - 2019 - Lasers in Surgery and Medicine - Wiley Online Library Perfluorodecalin‐infused patch in picosecond and Q‐switched laser‐assisted tattoo removal: Safety in Fitzpatrick IV–VI skin types - Vangipuram - 2019 - Lasers in Surgery and Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/abeb9014-40a0-48b9-8b5e-a4bb1503d92f/lsm23022-fig-0001-m.jpg)
Perfluorodecalin‐infused patch in picosecond and Q‐switched laser‐assisted tattoo removal: Safety in Fitzpatrick IV–VI skin types - Vangipuram - 2019 - Lasers in Surgery and Medicine - Wiley Online Library
![Eficacia de vismodegib en pacientes con carcinoma de células basales de alto riesgo - PDF Free Download Eficacia de vismodegib en pacientes con carcinoma de células basales de alto riesgo - PDF Free Download](https://docplayer.es/docs-images/80/82213294/images/9-0.jpg)
Eficacia de vismodegib en pacientes con carcinoma de células basales de alto riesgo - PDF Free Download
![Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f5da04fac11c2ecde69ee95d887325b41609a7f0/3-Figure3-1.png)
Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar
![The Prokinetic Cinitapride Has No Clinically Relevant Pharmacokinetic Interaction and Effect on QT during Coadministration with Ketoconazole | Drug Metabolism & Disposition The Prokinetic Cinitapride Has No Clinically Relevant Pharmacokinetic Interaction and Effect on QT during Coadministration with Ketoconazole | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/35/7/1149/F2.large.jpg)
The Prokinetic Cinitapride Has No Clinically Relevant Pharmacokinetic Interaction and Effect on QT during Coadministration with Ketoconazole | Drug Metabolism & Disposition
![Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f5da04fac11c2ecde69ee95d887325b41609a7f0/4-Figure7-1.png)